Head & Neck Cancer Study

A randomized double-blind phase 3 study of Avelumab in combination with standard of care chemoradiotherapy (Cisplatin plus definitive radiation therapy) versus standard of care chemoradiotherapy in the front-line treatment of patients with locally advanced squamous cell carcinoma of the head and neck